ASTRAZENECA PLC (ZEG.DE) Fundamental Analysis & Valuation
FRA:ZEG • GB0009895292
Current stock price
160.7 EUR
+0.95 (+0.59%)
Last:
This ZEG.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ZEG.DE Profitability Analysis
1.1 Basic Checks
- ZEG had positive earnings in the past year.
- In the past year ZEG had a positive cash flow from operations.
- Each year in the past 5 years ZEG has been profitable.
- ZEG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 8.96%, ZEG is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
- The Return On Equity of ZEG (21.01%) is better than 65.45% of its industry peers.
- The Return On Invested Capital of ZEG (13.63%) is better than 65.45% of its industry peers.
- ZEG had an Average Return On Invested Capital over the past 3 years of 12.48%. This is below the industry average of 14.61%.
- The 3 year average ROIC (12.48%) for ZEG is below the current ROIC(13.63%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.96% | ||
| ROE | 21.01% | ||
| ROIC | 13.63% |
ROA(3y)7.2%
ROA(5y)5.03%
ROE(3y)17.82%
ROE(5y)12.53%
ROIC(3y)12.48%
ROIC(5y)10.5%
1.3 Margins
- ZEG's Profit Margin of 17.41% is fine compared to the rest of the industry. ZEG outperforms 69.09% of its industry peers.
- In the last couple of years the Profit Margin of ZEG has grown nicely.
- ZEG has a Operating Margin of 23.86%. This is comparable to the rest of the industry: ZEG outperforms 58.18% of its industry peers.
- ZEG's Operating Margin has improved in the last couple of years.
- ZEG has a Gross Margin of 81.31%. This is amongst the best in the industry. ZEG outperforms 85.45% of its industry peers.
- In the last couple of years the Gross Margin of ZEG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.86% | ||
| PM (TTM) | 17.41% | ||
| GM | 81.31% |
OM growth 3Y6.24%
OM growth 5Y7.63%
PM growth 3Y32.91%
PM growth 5Y7.71%
GM growth 3Y0.34%
GM growth 5Y0.28%
2. ZEG.DE Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ZEG is creating some value.
- Compared to 1 year ago, ZEG has about the same amount of shares outstanding.
- The number of shares outstanding for ZEG has been increased compared to 5 years ago.
- Compared to 1 year ago, ZEG has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 3.77 indicates that ZEG is not in any danger for bankruptcy at the moment.
- With a Altman-Z score value of 3.77, ZEG perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
- The Debt to FCF ratio of ZEG is 3.42, which is a good value as it means it would take ZEG, 3.42 years of fcf income to pay off all of its debts.
- ZEG has a better Debt to FCF ratio (3.42) than 63.64% of its industry peers.
- ZEG has a Debt/Equity ratio of 0.55. This is a neutral value indicating ZEG is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.55, ZEG is in the better half of the industry, outperforming 61.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 3.42 | ||
| Altman-Z | 3.77 |
ROIC/WACC1.49
WACC9.14%
2.3 Liquidity
- ZEG has a Current Ratio of 0.94. This is a bad value and indicates that ZEG is not financially healthy enough and could expect problems in meeting its short term obligations.
- ZEG's Current ratio of 0.94 is on the low side compared to the rest of the industry. ZEG is outperformed by 81.82% of its industry peers.
- A Quick Ratio of 0.72 indicates that ZEG may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.72, ZEG is doing worse than 74.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.72 |
3. ZEG.DE Growth Analysis
3.1 Past
- The earnings per share for ZEG have decreased by -1.34% in the last year.
- Measured over the past years, ZEG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.04% on average per year.
- The Revenue has grown by 8.63% in the past year. This is quite good.
- ZEG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.15% yearly.
EPS 1Y (TTM)-1.34%
EPS 3Y6.74%
EPS 5Y15.04%
EPS Q2Q%-49.28%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y9.82%
Revenue growth 5Y17.15%
Sales Q2Q%4.11%
3.2 Future
- Based on estimates for the next years, ZEG will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.20% on average per year.
- Based on estimates for the next years, ZEG will show a small growth in Revenue. The Revenue will grow by 6.82% on average per year.
EPS Next Y30.41%
EPS Next 2Y20.69%
EPS Next 3Y17.63%
EPS Next 5Y15.2%
Revenue Next Year6.06%
Revenue Next 2Y5.93%
Revenue Next 3Y6.22%
Revenue Next 5Y6.82%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. ZEG.DE Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 23.53 indicates a rather expensive valuation of ZEG.
- ZEG's Price/Earnings ratio is in line with the industry average.
- The average S&P500 Price/Earnings ratio is at 24.88. ZEG is around the same levels.
- ZEG is valuated rather expensively with a Price/Forward Earnings ratio of 18.05.
- ZEG's Price/Forward Earnings ratio is in line with the industry average.
- ZEG is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.53 | ||
| Fwd PE | 18.05 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as ZEG.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZEG is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.09 | ||
| EV/EBITDA | 16.14 |
4.3 Compensation for Growth
- ZEG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- ZEG has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as ZEG's earnings are expected to grow with 17.63% in the coming years.
PEG (NY)0.77
PEG (5Y)1.56
EPS Next 2Y20.69%
EPS Next 3Y17.63%
5. ZEG.DE Dividend Analysis
5.1 Amount
- ZEG has a Yearly Dividend Yield of 1.64%. Purely for dividend investing, there may be better candidates out there.
- ZEG's Dividend Yield is comparable with the industry average which is at 1.89.
- ZEG's Dividend Yield is comparable with the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.64% |
5.2 History
- The dividend of ZEG has a limited annual growth rate of 3.33%.
Dividend Growth(5Y)3.33%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- ZEG pays out 48.62% of its income as dividend. This is a bit on the high side, but may be sustainable.
- The dividend of ZEG is growing, but earnings are growing more, so the dividend growth is sustainable.
DP48.62%
EPS Next 2Y20.69%
EPS Next 3Y17.63%
ZEG.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:ZEG (2/5/2026, 7:00:00 PM)
160.7
+0.95 (+0.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-10 2026-02-10/bmo
Earnings (Next)04-29 2026-04-29
Inst Owners49.17%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap249.13B
Revenue(TTM)58.74B
Net Income(TTM)10.22B
Analysts82.94
Price Target175.52 (9.22%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.64% |
Yearly Dividend2.7
Dividend Growth(5Y)3.33%
DP48.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-25.37%
Min EPS beat(2)-60.38%
Max EPS beat(2)9.64%
EPS beat(4)2
Avg EPS beat(4)-12.23%
Min EPS beat(4)-60.38%
Max EPS beat(4)9.64%
EPS beat(8)4
Avg EPS beat(8)-5.74%
EPS beat(12)7
Avg EPS beat(12)-2.63%
EPS beat(16)11
Avg EPS beat(16)-0.36%
Revenue beat(2)1
Avg Revenue beat(2)-1.31%
Min Revenue beat(2)-4.83%
Max Revenue beat(2)2.2%
Revenue beat(4)1
Avg Revenue beat(4)-2.92%
Min Revenue beat(4)-5.08%
Max Revenue beat(4)2.2%
Revenue beat(8)4
Avg Revenue beat(8)-0.54%
Revenue beat(12)5
Avg Revenue beat(12)-0.86%
Revenue beat(16)6
Avg Revenue beat(16)-0.78%
PT rev (1m)5.49%
PT rev (3m)12.4%
EPS NQ rev (1m)-1.75%
EPS NQ rev (3m)-1.48%
EPS NY rev (1m)1.58%
EPS NY rev (3m)-0.37%
Revenue NQ rev (1m)-0.41%
Revenue NQ rev (3m)-0.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.53 | ||
| Fwd PE | 18.05 | ||
| P/S | 5.03 | ||
| P/FCF | 34.09 | ||
| P/OCF | 20.28 | ||
| P/B | 6.07 | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.14 |
EPS(TTM)6.83
EY4.25%
EPS(NY)8.9
Fwd EY5.54%
FCF(TTM)4.71
FCFY2.93%
OCF(TTM)7.93
OCFY4.93%
SpS31.94
BVpS26.46
TBVpS-5.67
PEG (NY)0.77
PEG (5Y)1.56
Graham Number63.77
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.96% | ||
| ROE | 21.01% | ||
| ROCE | 16.8% | ||
| ROIC | 13.63% | ||
| ROICexc | 14.63% | ||
| ROICexgc | 59.47% | ||
| OM | 23.86% | ||
| PM (TTM) | 17.41% | ||
| GM | 81.31% | ||
| FCFM | 14.76% |
ROA(3y)7.2%
ROA(5y)5.03%
ROE(3y)17.82%
ROE(5y)12.53%
ROIC(3y)12.48%
ROIC(5y)10.5%
ROICexc(3y)13.49%
ROICexc(5y)11.39%
ROICexgc(3y)81.92%
ROICexgc(5y)83.55%
ROCE(3y)15.36%
ROCE(5y)12.92%
ROICexgc growth 3Y-25.55%
ROICexgc growth 5Y0.81%
ROICexc growth 3Y9.13%
ROICexc growth 5Y9.72%
OM growth 3Y6.24%
OM growth 5Y7.63%
PM growth 3Y32.91%
PM growth 5Y7.71%
GM growth 3Y0.34%
GM growth 5Y0.28%
F-Score7
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 3.42 | ||
| Debt/EBITDA | 1.36 | ||
| Cap/Depr | 103% | ||
| Cap/Sales | 10.05% | ||
| Interest Coverage | 10.65 | ||
| Cash Conversion | 73.79% | ||
| Profit Quality | 84.79% | ||
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 3.77 |
F-Score7
WACC9.14%
ROIC/WACC1.49
Cap/Depr(3y)80.57%
Cap/Depr(5y)64.46%
Cap/Sales(3y)8.93%
Cap/Sales(5y)7.69%
Profit Quality(3y)99.49%
Profit Quality(5y)775.68%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.34%
EPS 3Y6.74%
EPS 5Y15.04%
EPS Q2Q%-49.28%
EPS Next Y30.41%
EPS Next 2Y20.69%
EPS Next 3Y17.63%
EPS Next 5Y15.2%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y9.82%
Revenue growth 5Y17.15%
Sales Q2Q%4.11%
Revenue Next Year6.06%
Revenue Next 2Y5.93%
Revenue Next 3Y6.22%
Revenue Next 5Y6.82%
EBIT growth 1Y10.05%
EBIT growth 3Y16.67%
EBIT growth 5Y26.09%
EBIT Next Year23.4%
EBIT Next 3Y12.45%
EBIT Next 5Y11.39%
FCF growth 1Y19.18%
FCF growth 3Y6.21%
FCF growth 5Y31.64%
OCF growth 1Y22.88%
OCF growth 3Y14.12%
OCF growth 5Y24.88%
ASTRAZENECA PLC / ZEG.DE Fundamental Analysis FAQ
What is the fundamental rating for ZEG stock?
ChartMill assigns a fundamental rating of 5 / 10 to ZEG.DE.
What is the valuation status of ASTRAZENECA PLC (ZEG.DE) stock?
ChartMill assigns a valuation rating of 3 / 10 to ASTRAZENECA PLC (ZEG.DE). This can be considered as Overvalued.
What is the profitability of ZEG stock?
ASTRAZENECA PLC (ZEG.DE) has a profitability rating of 7 / 10.
What is the valuation of ASTRAZENECA PLC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ASTRAZENECA PLC (ZEG.DE) is 23.53 and the Price/Book (PB) ratio is 6.07.
Can you provide the expected EPS growth for ZEG stock?
The Earnings per Share (EPS) of ASTRAZENECA PLC (ZEG.DE) is expected to grow by 30.41% in the next year.